首页 | 本学科首页   官方微博 | 高级检索  
     

靶向EGFR的干扰RNA对卵巢癌耐药细胞凋亡的影响
引用本文:张 娇,陈爱平,戚玉言,王 斌. 靶向EGFR的干扰RNA对卵巢癌耐药细胞凋亡的影响[J]. 中国肿瘤生物治疗杂志, 2009, 16(6): 619-623. DOI: 10.3872/j.issn.1007-385X.2009.06.013
作者姓名:张 娇  陈爱平  戚玉言  王 斌
作者单位:1. 青岛大学医学院附属医院妇科,山东,青岛,266003
2. 青岛大学医学院,微生物学教研室,山东,青岛,266003
摘    要:目的:探讨RNA干扰表皮生长因子受体(epidermal growth factor receptor,EGFR)的表达对多药耐药卵巢癌细胞株SKOV3/DDP凋亡的影响。方法:构建携带EGFR小发夹干扰RNA(small hairpin RNA, shRNA)的重组表达载体(pEGFRshRNA),脂质体法转染入SKOV3/DDP细胞,同时设未转染对照组和非特异性干扰质粒CtrlshRNA对照组。RTPCR和免疫细胞化学法检测转染后SKOV3/DDP细胞内EGFR mRNA和蛋白的表达;流式细胞仪分析EGFR沉默后SKOV3/DDP细胞周期和凋亡率的变化。结果:与转染对照质粒组相比,转染pEGFRshRNA组细胞EGFR mRNA和蛋白的表达明显受抑制(P<001)。流式细胞仪检测结果显示:顺铂作用24 h后,pEGFRshRNA转染组细胞周期分布发生明显改变,与对照组和CtrlsiRNA组相比,G0/G1期细胞比例和凋亡率明显增加(P<0.01),而S期细胞比例显著降低(P<0.01);凋亡率显著升高。结论:靶向EGFR的干扰RNA可抑制SKOV3/DDP细胞中EGFR的表达,调节耐药细胞周期,促进耐药细胞凋亡。

关 键 词:卵巢肿瘤;RNA干扰;表皮生长因子受体;顺铂
收稿时间:2009-10-05
修稿时间:2009-11-08

Effect of EGFR targeted interference RNA on apoptosis of multidrug resistant ovarian cancer cells
ZHANG Jiao,CHEN Ai-ping,QI Yu-yan and WANG Bin. Effect of EGFR targeted interference RNA on apoptosis of multidrug resistant ovarian cancer cells[J]. Chinses Journal of Cancer Biotherapy, 2009, 16(6): 619-623. DOI: 10.3872/j.issn.1007-385X.2009.06.013
Authors:ZHANG Jiao  CHEN Ai-ping  QI Yu-yan  WANG Bin
Affiliation:Department of Gynecology, Affiliated Hospital of Qingdao Medical College, Qingdao University, Qingdao 266003, Shandong, China;Department of Gynecology, Affiliated Hospital of Qingdao Medical College, Qingdao University, Qingdao 266003, Shandong, China;Department of Gynecology, Affiliated Hospital of Qingdao Medical College, Qingdao University, Qingdao 266003, Shandong, China;Department of Microbiology, Qingdao Medical College, Qingdao University, Qingdao 266003, Shandong, China
Abstract:Objective:To investigate the effect of RNA-mediated interference EGFR (epidermal growth factor receptor) expression on the apoptosis of muitidrug-resisitant ovarian cancer cell line SKOV3/DDP. Methods: Small hairpin RNA (shRNA) targeting EGFR was synthesized and recombinant plasmid containing pEGFR-shRNA was constructed, pEGFR-shRNA was tansfected into SKOV3/DDP cells by liposome system, untransfected cells and SKOV3/DDP cells tansfected with nonspecific-shRNA (Ctrl-shRNA) were used as control. Expression of EGFR mRNA and protein in SKOV3/DDP cells was examined by RT-PCR and immunocytochemistry after transfection, respectively. The apopototic rates and cell cy-cles of SKOV3/DDP cells were detected by flow cytometry. Results: Compared with Ctrl-shRNA-transfected cells, the ex-pression of EGFR mRNA and protein in pEGFR-shRNA-transfected SKOV3/DDP cells was significantly inhibited. Flow cytometry results showed that cell cycle distribution in pEGFR-shRNA-transfected SKOV3/DDP cells was dramatically changed, and the apoptosis rate was significantly increased after further treatment with cisplatin for 24 h. Conclusion: EGFR-targeted interference RNA can inhibit the expression of EGFR in SKOV3/DDP cells, thereby regulating the cell cy-cle and increasing apoptosis of multidrug-resistant SKOV3/DDP cells.
Keywords:ovarian neoplasms   RNA interference   epidermal growth factor receptor (EGFR)   cisplatin
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号